Work

A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumors

Year: 2005

Type: article

Study design: Clinical Trial

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s00280-004-0950-7

Authors: Grace K. Dy, Ajit Suri, Joel M. Reid, Jeff A. Sloan, Henry C. Pitot, Steven R. Alberts, Richard M. Goldberg, Pamela J. Atherton, Lorelei J. Hanson, Patrick A. Burch, Joseph Rubin, Charles Erlichman, Alex A. Adjei

Institutions: Mayo Clinic, Eli Lilly (United States), Mayo Clinic Comprehensive Cancer Center (Minnesota)

Language: English

Topic: Cancer Treatment and Pharmacology

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Deutsches Krebsforschungszentrum, National Institutes of Health, National Cancer Institute, National Center for Research Resources

Awards: CLINICAL STUDIES OF SIGNAL TRANSDUCTION INHIBITORS, G2424197942, G447447039, General Clinical Research Center, Phase I Clinical Trials of Anticancer Agents, G932523968

OpenAlex ID: W2009774610

FWCI: 1.553

Cites: 20

Cited by: 23

Related to: 10